Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Sep;78(3):672-3.
doi: 10.1111/bcp.12358.

Response to: assessing the harms of polypharmacy requires careful interpretation and consistent definitions

Rupert A Payne, Gary A Abel, Anthony J Avery, Stewart W Mercer, Martin O Roland
Comment

Response to: assessing the harms of polypharmacy requires careful interpretation and consistent definitions

Rupert A Payne et al. Br J Clin Pharmacol. 2014 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Adjusted odds ratios showing the association between admission and number of regular medications (relative to no regular medications), for different degrees of multimorbidity in over 65-year-olds only. For each number of clinical conditions, the clusters represent different numbers of medications, from none (white), through 1 to 3, 4 to 6, 7 to 9 and 10 or more medications (black). Error bars are 95% confidence intervals. The model is based on data from 38 785 patients aged over 65 years from our original population . Number of mediactions: formula image, none; formula image, 1 to 3 (reference); formula image, 4 to 6; formula image, 7 to 9 formula image, 10 or more
See this image and copyright information in PMC

Comment on

References

    1. Kouladjian L, Hilmer SN, Chen TF, Le Couteur DG, Gnjidic D. Assessing the harms of polypharmacy requires careful interpretation and consistent definitions. Br J Clin Pharmacol. 2014;78:670–671. - PMC - PubMed
    1. Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol. 2014;77:1073–1082. - PMC - PubMed
    1. Nobili A, Licata G, Salerno F, Pasina L, Tettamanti M, Franchi C, De Vittorio L, Marengoni A, Corrao S, Iorio A, Marcucci M, Mannucci PM SIMI Investigators. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol. 2011;67:507–519. - PubMed
    1. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989–995. - PubMed
    1. Strehblow C, Smeikal M, Fasching P. Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients. Wien Klin Wochenschr. 2014;126:195–200. - PubMed

LinkOut - more resources